July 11, 2020

Volume X, Number 193

July 10, 2020

Subscribe to Latest Legal News and Analysis

July 09, 2020

Subscribe to Latest Legal News and Analysis

July 08, 2020

Subscribe to Latest Legal News and Analysis

FDA Pays Closer Attention to How Food and Dietary Supplement Companies Promote Their Products on Social Media

As consumers spend more time online during COVID-19, FDA has increased its oversight of product claims made through testimonials, customer reviews, and blog posts posted to company social media accounts and websites, as those may signal a company’s intent to communicate information about its products.  In particular, FDA has been concerned about products that claim to treat COVID-19 or products that make mental health claims.

FDA has sent out warning letters to manufacturers that make claims on social media, whether made directly by the company or endorsed by the company through a retweet on Twitter or a “like” on Facebook.  For example, on May 4, 2020, FDA sent a warning letter to Honey Colony LLC where it cited social media posts and retweets to claims that the company’s products could treat COVID-19.  In the letter, FDA noted that it reviewed the company’s Twitter and Instagram pages because the company used these sites to direct customers to buy products on the company’s website.

By way of background, FDA has viewed “retweets” or “likes” as company endorsement, as FDA considers social media posts and claims as part of a product’s labeling.  Under the Food, Drug and Cosmetic Act, labeling is defined as “written, printed or graphic material accompanying a product.”  The Agency has interpreted this to include infomercials, website, brochures, and social media as an extension of labeling; however, some argue that FDA has no jurisdiction over social media.  Instead, some argue that social media falls under the Federal Trade Commission’s (FTC) jurisdiction, as FTC regulates advertising.  We will continue to monitor any developments.

© 2020 Keller and Heckman LLPNational Law Review, Volume X, Number 156


About this Author

Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition...